STIP1 and cancer: STIP1 is a tumour-associated antigen (TAA)33; its overexpression has been identified in numerous cancers, including colorectal carcinoma34, pancreatic cancer35, cholangiocellular carcinoma36 and ovarian cancer37, and it is possibly associated with poor survival outcomes in patients with cancer38.